Current Cancer Drug Targets

Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor

Most Accessed Articles

COVID-19 Pandemic: Experiences in China and Implications for its Prevention and Treatment Worldwide

Volume: 20   Issue: 6
Pp: 410-416
Ning-Ning Liu*, Jing-Cong Tan, Jingquan Li, Shenghui Li*, Yong Cai* and Hui Wang*
DOI: 10.2174/1568009620666200414151419

CDK12 Promotes Breast Cancer Progression and Maintains Stemness by Activating c-myc/β -catenin Signaling

Volume: 20   Issue: 2
Pp: 156-165
Fang Peng, Chuansheng Yang, Yanan Kong, Xiaojia Huang, Yanyu Chen, Yangfan Zhou, Xinhua Xie* and Peng Liu*
DOI: 10.2174/1568009619666191118113220

C-Myc Signaling Pathway in Treatment and Prevention of Brain Tumors

Volume: 21   Issue: 1
Pp: 2-20
Milad Ashrafizadeh, Ali Zarabi, Kiavash Hushmandi, Ebrahim Rahmani Moghadam, Farid Hashemi, Salman Daneshi, Fardin Hashemi, Shima Tavakol, Reza Mohammadinejad, Masoud Najafi*, Namrata Dudha and Manoj Garg*
DOI: 10.2174/1568009620666201016121005

Clinical Outcomes and Safety of Patients Treated with NAb-Paclitaxel Plus Gemcitabine in Metastatic Pancreatic Cancer: The NAPA Study

Volume: 20   Issue: 11
Pp: 887-895
Martina Catalano, Giandomenico Roviello*, Raffaele Conca, Alberto D’Angelo, Valeria Emma Palmieri, Benedetta Panella, Roberto Petrioli, Anna Ianza, Stefania Nobili, Enrico Mini and Monica Ramello
DOI: 10.2174/1568009620999200918122426

Exosome as a Natural Gene Delivery Vector for Cancer Treatment

Volume: 20   Issue: 11
Pp: 821-830
Prasad Pofali, Adrita Mondal and Vaishali Londhe*
DOI: 10.2174/1568009620666200924154149

Identification of WDFY3 Neoantigens as Prognostic Markers in Longterm Survivors of Extrahepatic Cholangiocarcinoma

Volume: 20   Issue: 11
Pp: 875-886
Yingyi Wang, Bao Jin, Na Zhou, Zhao Sun, Jiayi Li, Qiao Chen, Xiangan Wu, Yi Zhou, Yue Shi, Xin Lu, Xinting Sang, Yilei Mao, Shunda Du*, Wenze Wang* and Chunmei Bai*
DOI: 10.2174/1568009620999200918121456

Tyrosine Kinase Inhibitors (TKIs) in Lung Cancer Treatment: A Comprehensive Analysis

Volume: 21   Issue: 1
Pp: 55-69
Sivakumar Murugesan, Jayakumar Murugesan, Seedevi Palaniappan , Sivasankar Palaniappan, Tamilselvi Murugan, Shahid S. Siddiqui and Sivakumar Loganathan*
DOI: 10.2174/1568009620666201009130008

Immune Checkpoint Inhibitors in AML-A New Frontier

Volume: 20   Issue: 7
Pp: 545-557
Rohit Thummalapalli, Hanna A. Knaus, Ivana Gojo and Joshua F. Zeidner*
DOI: 10.2174/1568009620666200421081455

MUC Glycoproteins: Potential Biomarkers and Molecular Targets for Cancer Therapy

Volume: 21   Issue: 2
Pp: 132-152
Chameli Ratan, Dalia Cicily K. D, Bhagyalakshmi Nair and Lekshmi. R. Nath*
DOI: 10.2174/1568009620666201116113334

Tumor Penetrating Peptide-Functionalized Tenascin-C Antibody for Glioblastoma Targeting

Volume: 21   Issue: 1
Pp: 70-79
Prakash Lingasamy, Anett-Hildegard Laarmann and Tambet Teesalu *
DOI: 10.2174/1568009620666201001112749

Targeting Six Hallmarks of Cancer in Ovarian Cancer Therapy

Volume: 20   Issue: 11
Pp: 853-867
Han Gong, Dan Nie and Zhengyu Li*
DOI: 10.2174/1568009620999200816130218

Selinexor (KPT-330), an Oral Selective Inhibitor of Nuclear Export (SINE) Compound, in Combination with FOLFOX in Patients with Metastatic Colorectal Cancer (mCRC) - Final Results of the Phase I Trial SENTINEL

Volume: 20   Issue: 10
Pp: 811-817
Sven Nilsson, Alexander Stein, Christian Rolfo, Anne L. Kranich, Julia Mann, Konstantinos Papadimitriou, Susann Theile, Stefanie Amberg and Carsten Bokemeyer*
DOI: 10.2174/1568009620666200628105727

ASPM Predicts Poor Clinical Outcome and Promotes Tumorigenesis for Diffuse Large B-cell Lymphoma

Volume: 21   Issue: 1
Pp: 80-89
Jingjing Wu, Zhengmei He, Yaning Zhu, Chao Jiang, Yuan Deng and Bin Wei*
DOI: 10.2174/1568009620666200915090703

Pentamethylquercetin Inhibits Hepatocellular Carcinoma Progression and Adipocytes-induced PD-L1 Expression via IFN-γ Signaling

Volume: 20   Issue: 11
Pp: 868-874
Zhi Li, Wen-Qi Gao, Peng Wang, Tian-Qi Wang, Wen-Chao Xu, Xin-Yu Zhu and Hui Liu*
DOI: 10.2174/1568009620999200730184514

Management of Prostate Cancer with Systemic Therapy: A Prostate Cancer Unit Perspective

Volume: 21   Issue: 2
Pp: 107-116
Fabio Campodonico*, Marco Ennas, Silvia Zanardi , Ekaterini Zigoura, Arnoldo Piccardo, Luca Foppiani, Concetta Schiavone, Lino Squillace, Andrea Benelli, Andrea De Censi , Filippo Grillo-Ruggieri and Carlo Introini
DOI: 10.2174/1568009620666201021163919

The Roles of Alternative Splicing in Tumor-immune Cell Interactions open access plus

Volume: 20   Issue: 10
Pp: 729-740
Yue Wang, Honglei Zhang*, Baowei Jiao*, Jianyun Nie*, Xiyin Li, Wenhuan Wang and Hairui Wang
DOI: 10.2174/1568009620666200619123725

Use of Small-molecule Inhibitory Compound of PERK-dependent Signaling Pathway as a Promising Target-based Therapy for Colorectal Cancer

Volume: 20   Issue: 3
Pp: 223-238
Wioletta Rozpędek, Dariusz Pytel, Adam Wawrzynkiewicz, Natalia Siwecka, Adam Dziki, Łukasz Dziki, J. Alan Diehl and Ireneusz Majsterek*
DOI: 10.2174/1568009620666200106114826

Overexpression of p62 Induces Autophagy and Promotes Proliferation, Migration and Invasion of Nasopharyngeal Carcinoma Cells through Promoting ERK Signaling Pathway

Volume: 20   Issue: 8
Pp: 624-637
Qiong Wu, Manlin Xiang, Kun Wang, Zhen Chen, Lu Long, Ya Tao, Yunlai Liang, Yahui Yan, Zhiqiang Xiao, Shiyang Qiu and Bin Yi*
DOI: 10.2174/1568009620666200424145122